Notably, the expression of METTL3 and IGF2BP2 was significantly upregulated in CRC tissues (Fig. 7B, C) and was positively correlated with POU6F2-AS1 expression (R = 0.6 and 0.51; Fig. 7D, E). This evidence concerns the gene IGF2BP2 and colorectal carcinoma.